Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Beyond triple-negative breast cancer: the need to define new subtypes.
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Welding
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beyond triple-negative breast cancer: the need to define new subtypes.
Beyond triple-negative breast cancer: the need to define new subtypes. Expert Rev Anticancer Ther. 2010 Aug; 10(8):1197-213.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Breast Neoplasms
Drug Delivery Systems
Female
Gene Expression Profiling
Humans
Receptor, ErbB-2
Receptors, Estrogen
Receptors, Progesterone
authors with profiles
Robin Jones